Skip to content
OpenCapital
Get started

Versigent VGNT Reimbursable engineering costs

Other financials

Income statement

See full
Revenue$2.2B+9.3%
Gross profit$244.0M-2.0%
Operating income$74.0M-39.8%
Net income$78.0M-17.9%

Balance sheet

See full
Cash & equivalents$282.0M—
Total debt$2.4B—
Total equity-$48.0M-103%
Total assets$4.9B—

Cash flow

See full
Operating cash flow$36.0M-10.0%
CapEx$66.0M+78.4%
Free cash flow-$30.0M-1,100%

Valuation

See full
Market cap$3.03B—

Returns & leverage

See full
Debt / equity0.2×—
Current ratio1.4×—

Where this comes from

Reported directly by Versigent in its filing.

Tagged under the XBRL concept vgnt:ReimbursableEngineeringCurrent.

The official record: Versigent ’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Versigent 's reimbursable engineering costs?
Versigent (VGNT) reported reimbursable engineering costs of $9M in Q1 2026.